You are here

Meeting Highlights

Chemotherapy Foundation Symposium XXV: Innovative Cancer Therapy for Tomorrow

Marvin M. Goldenberg, PhD, RPh, MS
Topics include galiximab, bendamustine, and rituximab for hematological malignancies; pazopanib for renal cell cancer; trastuzumab and lapatinib for breast cancer; sorafenib/temozomide for melanoma; and IRX-2 for head and neck cancer